Objective: The impact of type of resection for lung cancer, that is, pneumonectomy or lobectomy, on postoperative quality of life is not clearly defined. The aim of the study was to compare the changes in health-related quality of life in patients undergoing lobectomy or pneumonectomy for lung cancer. Methods: We performed a prospective, population-based, cohort study and used a validated quality-of-life instrument to gather information on health-related quality of life before and 6 months after surgery. The main outcome measures were fractional change in the Short Form-36 physical and mental component summary scores. Results: There was no statistically significant difference in any of the Medical Outcome Study 36-Item Short Form subscales or summary scores between the lobectomy (n = 101) and pneumonectomy (n = 16) group at baseline. There was a significant difference in the fractional change in the physical component summary score between the lobectomy and pneumonectomy group (À17% vs À32%, p = 0.04), but not in the mental component summary score (6.5% vs 12%, p = 0.72). Conclusions: Pneumonectomy had a larger negative impact on the physical aspect of health-related quality of life than lobectomy 6 months following surgery for lung cancer. The mental component of quality of life was not affected by the extent of surgical resection. #
Introduction
Surgery for early-stage non-small-cell lung cancer is a potentially curative treatment. Multiple studies investigated quality of life in patients after lung surgery [1] [2] [3] [4] [5] [6] [7] . Some were restricted to 3 months follow-up [3, 8] , and some others focussed on the elderly [7, 8] .
Pneumonectomy is preferred in order to treat centrally located or regionally advanced lung cancer in patients with satisfactory pulmonary reserve. However, pneumonectomy for early-stage non-small-cell lung cancer has been shown to have a negative impact on survival compared with lobectomy [9] . The effect of the magnitude of lung resection on early and late mortality and morbidity is not yet clearly defined, and neither is the impact of type of resection on postoperative quality of life. Even though a recent study addressed the effect of the extent of resection on postoperative quality of life [10] , more information is needed regarding the potential differences in postoperative quality of life between pneumonectomy and lobectomy.
We performed a prospective, population-based, cohort study and used a validated quality-of-life instrument to gather information on health-related quality of life before and 6 months after surgery. The aim of the study was to compare the changes in health-related quality of life in patients undergoing lobectomy or pneumonectomy for lung cancer.
Patients and methods
The study was approved by the regional Human Research Ethics Committee, Stockholm, Sweden. Informed consent was obtained from all patients.
April 2008, 250 patients scheduled for lung surgery at our department were included, and filled out the baseline Medical Outcome Study 36-Item Short Form (SF-36) questionnaire. Six months after the operation, the SF-36 questionnaire was sent to the patients by mail, and they were asked to fill out and return the questionnaire by mail. A reminder was sent out after 1 month to those patients who had not returned the questionnaire, and a final reminder was sent 1 month later.
Main outcome measures
The main outcome measures were fractional change in the SF-36 physical and mental component summary scores (DPCS% and DMCS%) calculated as:
Quality-of-life instrument
We used the Swedish version SF-36 questionnaire. The SF-36 is a standardised, self-administered survey measuring health-related quality of life [11] . The validity and reliability of the Swedish version has been evaluated [12] . The questionnaire consists of 36 items and measures health using eight subscales with 2-10 items per scale. The subscales and summary scores can be compared with the general population allowing norm-based interpretation. Scoring of the SF-36 was performed according to the methods described in the Swedish version of the SF-36 manual [11] . For each of the eight subscales, the score was summed and transformed to a scale of 0-100, representing the percentage of the highest possible score achieved. In all scales, higher score indicates better health. Several advantages of the PCS and MCS scores over the original eight scales of the SF-36 have been reported [11, 13] ; however, the summary scores should always be interpreted in combination with the subscale scores [14] . For the PCS score, very high scores indicate no physical limitations, disabilities or decrements in well-being as well as high energy level. Very low scores indicate substantial limitations in self-care, physical, social and role activities as well as severe bodily pain or frequent tiredness. For the MCS score, very high scores indicate frequent positive affect, absence of psychological distress and of limitations in usual social or role activities due to emotional problems. Very low scores indicate frequent psychological suffering, and substantial social and role disability due to emotional problems.
Definitions
Ischaemic heart disease was defined as a history of angina pectoris, myocardial infarction or re-vascularisation procedure (coronary artery bypass surgery or percutaneous coronary intervention).
Hypertension was defined as a history of high blood pressure requiring medication. Congestive heart disease was defined as a history of heart failure or left ventricular ejection fraction less than 0.5.
Diabetes mellitus was defined as diabetes requiring insulin or oral antidiabetics. Peripheral vascular disease was defined as a history of claudication, carotid stenosis or abdominal aneurysm. Cerebrovascular disease was defined as a history of stroke or transient ischaemic attack. Smoking status was divided into three categories: current, former and never smoker. Current smoker was defined as an active smoker or a person who had stopped smoking within 1 year of surgery; former smoker was defined as a previous smoker who had stopped smoking more than 1 year before surgery; and never smoker was defined as a person who had never been an active smoker. Estimated glomerular filtration rate was calculated using the Cockcroft-Gault formula. A diagnosis of pneumonia was made when there were clinical and radiological signs consistent with pneumonia requiring antibiotics.
Statistical analyses
Continuous variables are reported as mean, standard deviation or median and 95% confidence intervals. Comparisons regarding pre-, peri-and postoperative characteristics between the groups were performed with Fisher's exact test for categorical variables and the independent samples ttest for continuous variables. Preoperative and postoperative intra-group comparisons were performed with t-test for dependent samples. Quantile regression was used to estimate and compare the medians in absolute and fractional change in PCS and MCS scores because the distributions were not symmetrical. Quantile regression is a robust statistical method that makes no assumptions about the distribution of the outcome variable. Standard errors for the regression coefficients were obtained by generating 1000 bootstrap samples. Multivariable analysis by quantile regression was performed to explore the effect of potential confounders on the primary outcome measures. A twotailed p-value of 0.05 was used to indicate statistical significance. Statistical analyses were performed using SPSS 16.0 (SPSS, Chicago, IL, USA) and STATA 10.1 (Stata Corp, College Station, TX, USA).
Results
A baseline SF-36 questionnaire was completed by 250 patients. During 6 months follow-up, 14 patients died. Despite two reminders, 37 patients did not complete a follow-up SF-36 questionnaire 6 months after surgery. The response rate (as a percent of surviving participants) at 6 months was 84% (199/236). The response rate was 87% and 89% in the lobectomy group and pneumonectomy group, respectively. Forty-four patients were excluded due to sublobar resection or other type of surgery, and another 38 patients were excluded because of other diagnosis than primary lung cancer. Thus, the study group consisted of patients with primary lung cancer who underwent either lobectomy or pneumonectomy and had complete SF-36 questionnaires at both baseline and at 6 months after surgery (n = 117).
Preoperative patient characteristics are shown in Table 1 . All patients underwent muscle-sparing posterolateral thoracotomy, and postoperative management included thoracic epidural analgesia. No patient required prolonged ventilation; however, one patient was later re-intubated due to respiratory problems. Two patients underwent early reoperation due to bleeding. Other postoperative complications are shown in Table 2 . Tumour stage and histopathology are shown in Table 3 .
Health-related quality of life
The SF-36 subscale scores and the summary scores in the lobectomy and pneumonectomy groups before and 6 months after surgery are shown in Table 4 . There was no statistically significant difference in the SF-36 subscales or summary scores between the lobectomy and pneumonectomy group at baseline ( Fig. 1A ). Six months after surgery, the physical functioning and the vitality subscale scores were significantly lower in the pneumonectomy group compared to the lobectomy group ( Fig. 1B) .
Within the lobectomy group, there was a significant increase in the mental health subscale, and a significant decrease in the physical functioning, physical role functioning, bodily pain and general health scores 6 months after surgery ( Fig. 2A) . Within the pneumonectomy group, a significant decrease in the following subscales was noted 6 months postoperatively: physical functioning, physical role functioning, bodily pain and vitality (Fig. 2B) .
A comparison between lobectomy and pneumonectomy regarding changes in PCS and MCS scores is shown in Table 5 . There was a significant difference in the main outcome measure, DPCS%, between the lobectomy and pneumonectomy group (À17% vs À32%, p = 0.04). There was no significant difference in the other main outcome measure, DMCS%, between the lobectomy and pneumonectomy group (6.5% vs 12%, p = 0.72).
Adjuvant chemotherapy and quality of life
A larger proportion of patients in the pneumonectomy group, compared to the lobectomy group, received adjuvant chemotherapy (81% vs 31%, p < 0.001). In the multivariable analysis, including age, gender and type of surgery, adjuvant chemotherapy was significantly associated with a decrease in DPCS%, but not in the DMCS%. In the lobectomy group, adjuvant chemotherapy resulted in a DPCS% of À26%, compared to À13% in patients without adjuvant chemotherapy ( p = 0.003). The DPCS% in pneumonectomy patients receiving, and not receiving, adjuvant chemotherapy was similar (À32% vs À27%, p = 0.86).
Discussion
The main finding was that a clinically and statistically significant deterioration in the physical aspect of health- related quality of life 6 months following lung resection for lung cancer was more pronounced in patients undergoing pneumonectomy compared to lobectomy. There was no difference between the groups regarding the mental domain.
When should assessments of quality of life after lung surgery in lung cancer patients be performed?
Prior studies have shown conflicting results. One study reported return of quality of life to preoperative levels after 3 months [3] , and another showed similar results after 6 months [6] . In contrast, Handy et al. [4] found significantly lower values in five of the eight SF-36 subscales 6 months after lung cancer surgery. Kenny et al. [5] found an early worsening in the physical dimensions and overall quality of life, with later improvement at 4 months after surgery in patients without recurrent disease. However, in patients with recurrent disease almost all dimensions of quality of life deteriorated.
Survival differences after lobectomy and pneumonectomy
In a study of 340 lobectomies and 102 pneumonectomies, Ferguson and Karrison were unable to detect an important effect of pneumonectomy on long-term survival [15] . In contrast, Alexiou et al. found that patients who underwent pneumonectomy (n = 111) for stage T1N0 or T2N0 non-smallcell lung cancer had a significantly poorer survival than patients who underwent smaller lung resections (n = 374) [9] . Lung-saving procedures, such as sleeve lobectomy, have been shown to result in better early and long-term survival when compared to pneumonectomy [16] .
Quality of life after lobectomy and pneumonectomy
Myrdal et al. investigated quality of life following lung cancer [17] . At a mean follow-up of almost 2 years, they found that patients who underwent pneumonectomy (n = 22) had a significantly lower SF-36 PCS score than patients who had undergone lobectomy (n = 85). Even though our results agreed, their study was not designed to specifically study differences in quality of life between pneumonectomy and lobectomy, and lacked preoperative data on quality of life, and had variable follow-up time (4-48 months).
A prospective study of quality of life after lung cancer surgery showed that pneumonectomy (n = 17) was significantly associated with a worse quality of life when compared with lobectomy (n = 61) during a 12 months follow-up [1] . The investigators used the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire and Mean and standard deviation. found that there was no return to baseline in physical functioning, role functioning, pain, shoulder function and dyspnoea after pneumonectomy. Although the results were similar to those of our study, some important points should be considered when comparing conclusions. Firstly, in the study of Balduyck et al. [1] , baseline differences existed between pneumonectomy and lobectomy patients regarding several aspects of quality of life. Secondly, the pneumonectomy group consisted only of men, and the lobectomy group consisted of 10 women only (16%). In our study, there was no significant difference in the quality-of-life subscales or summary scores between the lobectomy and pneumonectomy group at baseline, and there was a more equal balance between genders as shown in Table 1 . In addition, care must be taken when interpreting results from studies using different quality-of-life instruments.
A recent prospective study compared quality of life in patients who underwent lobectomy (n = 131) and pneumonectomy (n = 28) [10] . At 6 months after surgery, the response rate in survivors was 98%, and social function, role function, global health and pain were significantly worse in the pneumonectomy group. These results may be biased from a significantly higher proportion of postoperative complications (29% vs 13% major complications) and hospital stay (20 days vs 14 days) in the pneumonectomy group.
We noted that adjuvant chemotherapy in lobectomy patients had a negative influence on the physical component of quality of life, expressed as 13 percentage points worse fractional change in PCS ( p = 0.003). The mental component remained unchanged. However, our study was not designed to analyse the underlying reasons for changes in quality of life, and this finding must be interpreted cautiously.
Limitations of the study
Patients were not truly consecutive. For administrative and other reasons, not all patients planned for surgery for lung cancer were approached and screened for inclusion in this study. However, we believe there was a low risk of introducing bias, such as a systematic inclusion of only healthy and fit patients that may limit the conclusions to be drawn from this study.
Low response rate is a frequent problem in quality-of-life studies, and it can potentially introduce bias. In our study, the overall response rate was 84% and it was similar in both groups (89% and 87%). Therefore, we do not think that the response rate has distorted our results in a major way.
Another limitation is the use of only one quality-of-life instrument. A disease-specific instrument could provide additional important information. However, the inclusion of multiple quality-of-life questionnaires might reduce the response rate.
Conclusions
Pneumonectomy had a larger negative impact on the physical aspect of health-related quality of life than lobectomy 6 months following surgery for lung cancer. The mental component of quality of life was not affected by the extent of surgical resection. 
